Safety, efficacy and extended duration of action of mixed amphetamine salts extended- release capsules for the treatment of ADHD

Author： Weisler Richard H  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.6, 2005-06, pp. : 1003-1017

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety

By Yadav Rahul   France Michael   Younis Naveed   Hama Salam   Ammori Basil J   Kwok See   Soran Handrean  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1345-1362

Informa Healthcare

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules: In Bipolar I Disorder

By Tracy Swainston Harrison   Keating Gillian M.  

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 709-716

Adis International

Access to resources Recommend Favorite

Extended Release Alpha-2 Agonists for ADHD

By  

Child and Adolescent Psychopharmacology News, Vol. 18, Iss. 2, 2013-04 ,pp. : 7-9

Guilford Publications Inc

Access to resources Recommend Favorite

Fed and Fasted Administration of a Novel Extended‐Release Methylphenidate Orally Disintegrating Tablet Formulation for the Treatment of ADHD

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 160-167

John Wiley & Sons Inc

Access to resources Recommend Favorite

Extended-Release Formulations for the Treatment of Epilepsy

By Bialer Meir  

CNS Drugs, Vol. 21, Iss. 9, 2007-01 ,pp. : 765-774

Adis International

Access to resources Recommend Favorite